HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Acute hepatic failure — Clinical Guidelines

Overview

Acute hepatic failure (AHF) is a severe condition characterized by rapid deterioration of liver function, potentially leading to multi-organ failure and death. It can result from various etiologies including toxic exposures (e.g., aflatoxins, acetaminophen), genetic disorders (e.g., infantile liver failure syndrome type 1), and other metabolic or infectious triggers 1 3.

Diagnosis

Clinical Presentation: Jaundice, ascites, encephalopathy, coagulopathy 1 3.

Laboratory Tests: Elevated liver enzymes (ALT, AST), prolonged PT/INR, hypoalbuminemia, hyperbilirubinemia 1 3.

Imaging: Abdominal ultrasound or CT to assess liver morphology and rule out other causes 1.

Serum Acetaminophen Levels: For suspected drug overdose, measure timed serum acetaminophen concentrations 4 8.

Genetic Testing: Consider in neonates with suspected infantile liver failure syndrome type 1 3.

Management

First-Line Treatment:

- Acetaminophen Overdose: Intravenous N-acetylcysteine (IV-NAC) as the antidote 6 8. - Acute Aflatoxicosis: Supportive care, including liver transplantation in severe cases 1.

Adjunctive Therapies:

- Hemodynamic Support: Manage fluid balance and potential circulatory dysfunction 1. - Coagulopathy Management: Fresh frozen plasma, vitamin K, and clotting factor concentrates as needed 1. - Liver Transplantation: Consider for irreversible liver failure 1.

Special Populations

Pregnancy: Acute hepatic steatosis of pregnancy requires careful monitoring and management; AI tools can assist in evaluating resident competencies 2.

Pediatrics: Infantile liver failure syndrome type 1 necessitates early genetic testing and supportive care 3.

Elderly: Increased susceptibility to complications; individualized management based on comorbidities 1.

Comorbidities: Consider additional risks and tailor treatment plans accordingly, especially in cases of concurrent renal insufficiency 9.

Key Recommendations

Initiate IV-NAC promptly in suspected acetaminophen overdose to mitigate hepatotoxicity (Evidence: Strong 6 8).

Evaluate serum acetaminophen levels and timing of ingestion to guide treatment intensity (Evidence: Moderate 8).

Consider liver transplantation for patients with irreversible liver failure (Evidence: Expert opinion 1).

Utilize genetic testing in neonates with suspected infantile liver failure syndrome type 1 to guide management (Evidence: Moderate 3).

Implement comprehensive supportive care including hemodynamic and coagulation management in acute hepatic failure (Evidence: Moderate 1).

References

1 Goessens T, Tesfamariam K, Njobeh PB, Matumba L, Jali-Meleke N, Gong YY et al.. Incidence and mortality of acute aflatoxicosis: A systematic review. Environment international 2025. link 2 Desseauve D, Lescar R, de la Fourniere B, Ceccaldi PF, Dziadzko M. AI in obstetrics: Evaluating residents' capabilities and interaction strategies with ChatGPT. European journal of obstetrics, gynecology, and reproductive biology 2024. link 3 Hirata K, Okamoto N, Ichikawa C, Inoue S, Nozaki M, Banno K et al.. Severe course with lethal hepatocellular injury and skeletal muscular dysgenesis in a neonate with infantile liver failure syndrome type 1 caused by novel LARS1 mutations. American journal of medical genetics. Part A 2021. link 4 Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. American journal of preventive medicine 2011. link 5 Manthripragada AD, Zhou EH, Budnitz DS, Lovegrove MC, Willy ME. Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and drug safety 2011. link 6 Zyoud SH, Awang R, Syed Sulaiman SA, Sweileh WM, Al-Jabi SW. Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose. Human & experimental toxicology 2010. link 7 Ferris M, Hasket M, Pilkington S, Williams M. Financial analysis of acetaminophen suicide in a teen girl. Pediatric nursing 2007. link 8 Sivilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Annals of emergency medicine 2005. link 9 von Mach MA, Hermanns-Clausen M, Koch I, Hengstler JG, Lauterbach M, Kaes J et al.. Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 cases. Clinical toxicology (Philadelphia, Pa.) 2005. link 10 Aidinis V, Sekeris CE, Guialis A. Two immunologically related polypeptides of 72/74 kDa specify a novel 70-100S heterogeneous nuclear RNP. Nucleic acids research 1995. link 11 Urban-Grimal D, Volland C, Garnier T, Dehoux P, Labbe-Bois R. The nucleotide sequence of the HEM1 gene and evidence for a precursor form of the mitochondrial 5-aminolevulinate synthase in Saccharomyces cerevisiae. European journal of biochemistry 1986. link

Acute hepatic failure